Tuesday, November 5, 2019

Allogene Therapeutics EPS beats by $0.05

Allogene Therapeutics (NASDAQ:ALLO): Q3 GAAP EPS of -$0.50 beats by $0.05.
Cash, equivalents and investments of $601.95M.
Press Release
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.